suicidality - Page 1 | CARLAT PUBLISHING

Clinical Update

Treating Pediatric Bipolar Disorder: More Than Just Medicine

October 1, 2026

Anthony Charuvastra, MD and Roseanne Mauch, MD

Anthony Charuvastra, MD. Assistant Professor, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Roseanne Mauch, MD. Assistant Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai, New York, NY.

Drs. Charuvastra and Mauch have no financial relationships with companies related to this material.

Most bipolar youth need care beyond medication alone. This update reviews family-focused therapy and dialectical behavior therapy for adolescents, addressing family communication, suicidality, and sleep problems, and offers practical guidance on selecting approaches and locating properly trained therapists for families.

Why We Miss Suicide Risk in Autistic Youth

June 1, 2026

Joshua D. Feder, MD and Mara Goverman

What if the patients we assume are safest from suicide are actually the ones we miss? Today we're talking about suicide risk in autistic youth, why it's higher than many clinicians expect, how distress shows up differently, and what small changes in our assessment process and treatment can make a real difference.

Research Update

Does Ketamine’s Effect on Suicidality Stick Around?

June 1, 2026

Hassan Mobarak, MD. Dr. Mobarak has no financial relationships with companies related to this material.

Ketamine is one of the few medications in psychiatry that reduces suicidal ideation (SI).

4 Keys to Discharging Patients Who Refuse To Leave

May 25, 2025

Daniel Carlat, MD

Expert Q&A

Suicide Assessment and Treatment

August 1, 2024

David A. Jobes, PhD, ABPP

David A. Jobes, PhD, ABPP

Professor of Psychology and Associate Director of Clinical Training at The Catholic University of America in Washington, DC; Director of the Catholic University Suicide Prevention Lab (CatholicU SPL); Adjunct Professor of Psychiatry, School of Medicine, Uniformed Services University of the Health Sciences; author of Managing Suicidal Risk: A Collaborative Approach (3rd ed.) (Guilford Press; 2023).

Dr. Jobes is the founder and co-owner of CAMS-care, LLC, which offers training in Collaborative Assessment and Management of Suicidality. He receives royalties from Guilford Press. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.

David Jobes describes the Collaborative Assessment and Management of Suicidality framework, a problem-focused treatment, designed to provide a sense of agency to patients considering suicide.

Clinical Update

Novel Treatment Options for OCD

August 1, 2024

Edmund S. Higgins, MD

Edmund S. Higgins, MD. Clinical Associate Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina.

Dr. Higgins reports stock ownership in Bristol-Myers-Squibb and Johnson & Johnson. Dr. Aiken has reviewed this educational activity and determined that there is no commercial bias as a result of this financial relationship.

What do you do when SSRIs fail in OCD?

Research Update

Initiation of Gender-Affirming Hormones and Mental Health Outcomes

January 31, 2024

Erin Conklin, MSN, CNP, PMHNP-BC

Erin Conklin, MSN, CNP, PMHNP-BC. Ms. Conklin has no financial relationships with companies related to this material.

A study on gender-affirming hormones in adolescents and adults found they are linked to better mental health in transgender people, leading to reduced psychological distress and suicidal thoughts. The findings reinforce the Endocrine Society's advice to provide transgender adolescents with access to GAH.

Addressing Suicidality in Autistic Children and Teens

September 25, 2023

Joshua Feder, MD, Mara Goverman, and Paul Lipkin, MD

Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Autistic kids and teens can become despondent or suicidal. This episode explores the distinction between self-injurious behavior and suicidality in autistic children, communication patterns related to suicide, the screening process for identifying suicidality, and the different levels of care required to effectively address this issue.

RESEARCH UPDATE

Antidepressants for Suicidal Ideation in Depressed Patients?

July 1, 2022

James Black, MD

James Black, MD. Dr. Black has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants reduce suicidality even among patients who remain depressed.

Electroconvulsive Therapy: A Primer

March 23, 2022

Stephen J. Seiner, MD

Stephen J. Seiner, MD Director of neurotherapeutics, McLean Hospital. Belmont, MA. Dr. Seiner has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Seiner runs one of the busiest ECT programs in the country and speaks to us about recent innovations in the procedure. He also tells us which patients are the best candidates and shares tips for how to prolong ECT’s benefits.